Navigation Links
Women and Capital: Two words that dont always marry

ld in Chicago, she made it as far as the third round of discussions, but lost on the fourth because she hadn't yet sold any software. Since then, she's made sales to two schools, so she hopes for better luck next time.

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Women and Capital Two words that dont always marry

(Date:11/23/2009)...v. 23, 2009 In a provocative new study, a Univers...oxide emissions the major cause of global warming...collapses or society builds the equivalent of one ...nlikely that there will be any substantial near-te...n carbon dioxide emission rates," says the new pap...
(Date:11/23/2009)...N,Nov.23/PRNewswire-FirstCall/-YMBioSciencesInc.(N...entcompanythatidentifiesandadvancesadiverseportfol...ofdevelopment,todayreportedthatCytopia(ASX:CYT)has...87,apotent,orally-administeredJAK1/JAK2inhibitor.T...nesota.AproposaltomergeCytopiaintoYMhasbeenpreviou...
(Date:11/23/2009)...Calif.,Nov.23/PRNewswire/--Frost&Sullivan,theG...fordemonstratingleadershipandinnovationThursday,No...AwardsBanquetheldinSanAntonio,Texas. ,, (Logo: ...O ) ,, TheHealthcareInnovationAwardsaregiventoc...eliveryandmanagementofhealthcare.Suchcompanieshave...
(Date:11/20/2009)... Nov. 20 Veridiam (www.veridiam.co...ze company category at the 2009 Workplace Excellen...go Society for Human Resources Management and reco...ractices. ,, Veridiam was one of nine winners, ...panies, honored at the recent awards ceremony. San...
Breaking Biology Technology:Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2
...PRNewswire-FirstCall/ - Victhom Human Bionics Inc....ing of its updated corporate Website at www.victh... highlights advances in the Company,s two operatin...mplantable neurostimulation device for gait disord...cturing computerized prostheses for above-knee amp...
..., Jan. 9 Schering-Plough Corporation (NYSE: SGP...tion by Thomas P. Koestler, Ph.D., executive vice ...Institute, at the 27th Annual J.P. Morgan Healthca... at approximately 3:30 p.m. (PST) (6:30 p.m. EST).... R&D pipeline and select projects in developme...
... TRIANGLE PARK, N.C. and SANTA CLARA, Calif., Jan....oday that GSK has resubmitted the New Drug Applica...n (FDA) requesting approval of Solzira (TM) (gaba...he treatment of moderate-to-severe primary Restles...d that the data in a single study be reformatted. ...
Other Biology Technology:Victhom Announces Launch of Enhanced Company Website 2GSK and XenoPort Resubmit New Drug Application for Solzira(TM) in Restless Legs Syndrome 2GSK and XenoPort Resubmit New Drug Application for Solzira(TM) in Restless Legs Syndrome 3
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wildlif...ort revealing that the last remaining population o...y due to the rising tide of poaching and habitat l... inform Russian officials of what needs to be done...iggest cat. , The report was releas...
(Date:11/24/2009)..., Md. (November 24, 2009) New research on bacteri...cosystems reveals predictable temporal patterns, s...ies as markers for monitoring climate change in th... the Proceedings of the National Academy of Scien...es in the six rivers shifted synchronously over ti...
(Date:11/23/2009)...n, D.C. The community-associated strain of the de...sistant to most common antibioticsposes a far grea...ing its way into hospitals, according to a study i...ses . , The new threat is easily picked up in f...nd has increased the overall burden of MRSA within...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2New study finds MRSA on the rise in hospital outpatients 2Reward Yourself by Taking Your Dog to Obedience Training 58083 1Reward Yourself by Taking Your Dog to Obedience Training 58083 2Anthem Blue Cross and Blue Shield Awarded NCQAs Accreditation Status of Excellent 58081 1Anthem Blue Cross and Blue Shield Awarded NCQAs Accreditation Status of Excellent 58081 2Catholics to Rally at USCCB Headquarters in Washington DC Re 3A Healthcare Our Bishops and Abortion 58079 1Catholics to Rally at USCCB Headquarters in Washington DC Re 3A Healthcare Our Bishops and Abortion 58079 2
...HOUSTON -- (Nov. 19, 2008) -- Rice University scie...e stubborn pollutant TCE have created a method tha...ace of a catalyst as individual chemical bonds are...of the bonds between the atoms of our molecules," ... these vibrations change frequency and intensity w...
...MADISON, WI, NOVEMBER 17, 2008 Global land use pat...demand creative urban stormwater management. Tradi... the flow of runoff to waterways, but generally do...d by extensive pavement and compacted urban soils ...portunities affects groundwater recharge and has n...
...BOZEMAN -- The U.S. Department of Energy on Monday...stration Partnership at Montana State University t...f carbon dioxide into the sandstone rock layer ben...third and final phase of federal funding for the B...mately $14 million of the federal money will stay ...
Other Biology News:Researchers shed new light on catalyzed reactions 2Researchers shed new light on catalyzed reactions 3Urban trees enhance water infiltration 2Montana State partnership receives $66.9M for carbon sequestration 2Montana State partnership receives $66.9M for carbon sequestration 3
Mouse Anti-Protein Kinase C Beta 2 Monoclonal Antibody, Unconjugated from AbD Serotec
Mouse/Rat Anti-Canine CD3 / CD4 Dual Colour Reagent Antibody, FITC / R-Phycoerythrin Conjugated from AbD Serotec
Sheep Anti-DEHYDROEPIANDROSTERONE (+DEAHS) Polyclonal Antibody, Unconjugated from AbD Serotec
Mouse Anti-POLY (ADP-RIBOSE) (PAR) Monoclonal Antibody, Unconjugated from AbD Serotec
Biology Products: